Requires a patient and prescribing practitioner to have access to a clear, readily accessible, and convenient process to request a step therapy exception override determination when coverage of a prescription drug for the treatment of a medical condition is restricted for use by a carrier or utilization review organization through the use of a step therapy protocol.